Biotech pushes Congress to allow new incentive to help capital-hungry startups

The biotech industry has an idea for turning its current cash crisis into a windfall, and it's turning to Congress to try to make it happen.

Previous CHOP falls in U.S. News rankings of top children's hospitals after three years as nation's No. 2
Next Colorado Health Institute CEO leaving after nearly 12 years